Regulation & policy

‘Two sides of the same coin’: Industry and regulators signal a smarter, collaborative era for supplement oversight

At the first East Coast gathering of the SoCal Dietary Supplement Consortium, U.S. Food and Drug Administration officials and industry leaders framed supplement regulation around modernization, risk-based enforcement and practical collaboration.

FSANZ proposes minimum vitamin D levels, new labelling rules for toddler milk

Food Standards Australia New Zealand (FSANZ) is proposing a new set of regulations for toddler milk, including minimum vitamin D levels, permitted protein sources and new product labelling rules.

Probiota Americas 2026: Market dynamics, regulations, microbiome mitigation of environmental pollutants, and companion animals headline Day 1

Probiota Americas is less than two weeks away with must-see speakers on Day 1 including Nick Gibson (Nielsen IQ), Peter McMath (WPIC), Dr. Stan Kubow (McGill University), Dr Martha Cline (Nestlé Purina Petcare), Dr. Anna Lindell (Cambiotics), and more!

Across the Nutraverse: Jenerise creatine, France bans CBD edibles, U.S. Dietary Supplements Access Act

Catch up with our weekly round-up of key news from across the Nutraverse.

Regulatory review: India’s ashwagandha leaf ban, FTA with New Zealand and more

India’s ban on ashwagandha leaf use in food products and its free trade agreement (FTA) on manuka honey and bulk infant formulas with New Zealand are some of the latest updates in this regulatory news round-up.

Added fibre: Why fortification is harder than it looks

Adding fibre to foods and beverages could help close the ‘fibre gap’, but reformulation challenges threaten taste and texture

Senate bill would let HSAs & FSAs cover dietary supplements

Senators Kevin Cramer (R-ND) and John Curtis (R-UT) have introduced the Dietary Supplements Access Act to amend the Internal Revenue Code to recognize dietary supplements as qualified medical expenses eligible for reimbursement through Health Savings...

Moringa recalls spotlight pathogen risks across botanical supply chains

The FDA investigation, which closed April 1, tied recalled moringa supplements to more than 100 illnesses, drawing renewed industry attention to testing, traceability and supplier verification practices.

France bans CBD edibles, European agency agrees on ‘reproductive toxicant’ classification

France has banned CBD edibles and convinced the European Chemicals Agency (ECHA) that CBD should be treated as a reproductive toxicant, adding pressure on an “already fragile and highly uncertain” market.

Growth Asia Summit 2026: China and Indonesia markets to take centre stage

Industry experts from China and Indonesia detail the latest trends, policies and insights from these two crucial markets at this year’s Growth Asia Summit 2026.

European expansion through replication: The costly regulatory pitfall

The European Union is perceived as a single market, but in the food supplements sector, this assumption is one of the most common sources of regulatory risk across Europe.

News in brief

Donald Prater steps in as head of FDA Human Foods Program

The U.S. Food and Drug Administration has named Donald Prater acting deputy commissioner of the Human Foods Program, replacing Kyle Diamantas who was promoted to acting FDA commissioner days earlier.

FDA investigator outlines issues with gummy manufacturing

Supplement gummy production is known for being challenging as companies must consider everything from sugar content to foreign material exposure.

News in brief

Indian high court grants interim stay on ashwagandha leaf ban

The Karnataka High Court in Bangalore has temporarily stayed the Indian government’s restriction on the use of ashwagandha leaves issued last month after industry stakeholders challenged the rationale behind the blanket ban.

NutraCast: How Military Energy Gum became the first NSF Certified for Sport gum product

What started as a military solution for fatigue has evolved into one of the more unexpected formats in performance nutrition: Military Energy Gum (MEG). The chewable delivery system was originally developed for warfighters and has become the first gum...

EC clarifies Novel Food status of concentrated olive extracts

The European Commission has updated its Novel Food Catalogue to clarify the regulatory status of olive-derived ingredients. 

NPA Fly-in Day 2026: Championing health freedom 90 years on

Over 130 members of the Natural Products Association gathered on Capitol Hill on Tuesday for a day of meetings with legislators to champion consumer access to natural products—the organization’s fighting mission for the last 90 years.

NAD decision on magnesium gummies raises questions around compound weight claims

The ruling adds to broader industry discussion about how mineral forms and elemental nutrient amounts are communicated to consumers.

FDA Shakeup: Makary steps down, Diamantas steps up

The leadership transition at the U.S. Food and Drug Administration adds uncertainty for industries navigating shifting enforcement and public health priorities.

EFSA issues positive safety opinion on EffePharm’s NMN

The European Food Safety Authority (EFSA) has issued a positive safety opinion on EffePharm’s  β-NMN (nicotinamide mononucleotide), moving the novel food within reach of EU approval.

India-New Zealand FTA: NZ health product firms on opportunities, challenges

India and New Zealand recently inked a free trade agreement (FTA) that allows nutritional products such as manuka honey and bulk infant formula from New Zealand to be imported at lower tariff rates — a move that could promote new business, but also comes...

Behind the scenes tour: From ingredients to the shelf

A recent tour through several facilities in Tempe, Arizona, offered a behind-the-scenes look at the dietary supplement industry. From raw ingredient sourcing and testing to formulation, manufacturing and finished products, what ultimately reaches store...

NutraCast: How Nutrify C-Suite SumFlex is redefining industry events

As India’s nutraceutical sector continues to accelerate onto the global stage, the upcoming Nutrify C-Suite SumFlex Summit in Mumbai is positioning itself less as a traditional conference and more as a high-level working boardroom for industry leaders.

Guest column

Canada update: Red tape reduction in the natural health products sector

Canada’s natural health products (NHP) sector, referred to as dietary supplements in the United States, continues to face a persistent gap between policy intent and operational reality.

FDA flags eBay listing over GLP-1 claims in rare warning letter

The U.S. Food and Drug Administration (FDA) rarely goes after eBay sellers, which is exactly why it caught Asa Waldstein’s eye.

National Advertising Division refers Iron Rock NAD+ claims to regulators as participation dynamics come into focus

The BBB National Programs’ National Advertising Division (NAD) has referred Iron Rock Ventures LLC to regulatory authorities after the company did not confirm whether it would comply with recommendations to modify or discontinue certain advertising...

ICSB 2026: Distinguishing the old from the new through scientific rigor

The definition of dietary supplement ingredients was top of the agenda at this year’s International Conference on the Science of Botanicals (ICSB), with speakers exploring origin, production method and constitution of products delivered by an industry...

FDA’s largest infant formula test yet finds ‘low’ contaminants – but no new rules

FDA’s infant formula test found mostly trace contaminants, but without standards, enforcement or pre‑market testing, the data leaves critical questions unanswered

Across the Nutraverse: India’s ashwagandha leaf ban, prebiotics in Canada, sports nutrition opportunity

Catch up with our weekly round-up of key news from across the Nutraverse.

Rep. Langworthy continues push for Dietary Supplement Regulatory Uniformity Act

The bill aims to clarify federal preemption so that supplements meeting FDA requirements are not subjected to a patchwork of laws at the state level.

Health Canada publishes prebiotics monograph

Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) has published a monograph for prebiotics, establishing a clear set of rules and the basis for health claims in Canada.

Supplement industry unites around innovation-forward interpretation for ‘dietary substance’

There is widespread alignment in the industry on the key questions posed by the FDA following the March 27 FDA public meeting to explore the scope of dietary supplement ingredients, with the majority supporting a broad and innovation-forward approach to...

India bans ashwagandha leaf use in any form, industry reacts

On April 16, the Indian government issued an advisory restricting the use of ashwagandha leaves in crude or extract or any other form in food products, catching many industry stakeholders by surprise.

Across the Nutraverse: Clinical trials for active women, Andrographis in Australia, MPL in the House

Catch up with our weekly round-up of key news from across the Nutraverse.

South Korea’s MFDS reiterates ban on Gymnema sylvestre, Bacopa in supplements

South Korea’s Ministry of Food and Drug Safety (MFDS) has reiterated its ban on some of the commonly used ingredients in health supplements, including Gymnema sylvestre and Bacopa, due to concerns around side effects such as hepatitis and abdominal pain.

Regulatory review: Andrographis, caffeine warning, biotics and more

The potential removal of Andrographis as a low-risk ingredient in Australia, additional caffeine label warning for sports foods in ANZ and biotics regulations in Europe are some of the latest updates in this regulatory news round-up.

FTC order in TruHeight case signals scrutiny of height claims and incentivized reviews

The Federal Trade Commission’s (FTC) action against TruHeight is providing the dietary supplement industry with a detailed look at how the agency is approaching claim substantiation, youth-targeted marketing and consumer review practices, combining...

Timeline: Is CBD heading towards a frozen market in the UK?

Recently published minutes from a closed Food Standards Agency board meeting indicate that CBD approvals will be delayed further and are unlikely to occur before the end of summer 2026, raising questions as to whether this could effectively freeze the...

Heart health claim for soy protein in ANZ set to accelerate innovation – IFF

The approval of heart health claim for soy protein in Australia and New Zealand (ANZ) will open up opportunities for brands to accelerate innovation in plant-based nutrition to meet regional consumer needs, says ingredient giant IFF.

Dietary Supplement Listing Bill introduced in the House

A first-term member of Congress has introduced the Dietary Supplement Listing Act of 2026 in the U.S. House of Representatives to require dietary supplement manufacturers to list their products with the Food and Drug Administration (FDA).

Australian regulator consults on removal of Andrographis as low-risk ingredient

Australia’s Therapeutic Goods Administration (TGA) has begun a consultation with stakeholders on removing Andrographis paniculata (Andrographis) from the list of low-risk ingredients permitted for use in listed medicines, including health supplements.

‘Not as bad as the media says’: Future Nutra Foundation pushes transparency via new testing initiative

Transparency is taking center stage in the supplement industry and the Future Nutra Foundation is launching an effort to independently test products off the shelf and make those results publicly accessible.

Supplements 101: Biotic regulations in the European Union

Biotics are one of the fastest growing categories within the dietary supplement industry, but strict regulations within the European Union often prevent supplement companies from effectively communicating their benefits.

EU continues CBD scrutiny, rejecting 6 more novel food applications

The European Commission has terminated a backlog of cannabidiol (CBD) novel food applications for lack of data and non-compliance.

Thinking outside the box: FDA human foods chief talks MAHA priorities for supplement modernization

With making America healthy again at the top of the public agenda, Kyle Diamantas discussed FDA’s focus on dietary supplement modernization, the reform of ingredient safety pathways and stronger oversight of the global supply chain.

NAD flags Bayer One A Day men’s fertility positioning

The National Advertising Division (NAD) has recommended that Bayer HealthCare LLC discontinue or modify a series of claims tied to its One A Day Men’s Pre-Conception Health Complete Multivitamin, concluding that product positioning and messaging conveyed...

Caffeine in review: FSANZ adds advisory, warning statements for sports foods

Formulated supplementary sports foods (FSSF) containing caffeine will need to add new advisory and warning statements, says the Foods Standards Australia New Zealand (FSANZ).

Vietnam’s food safety overhaul moves forward after months of delay

After a disastrous attempt to implement new food safety regulations in January, Vietnam has taken next steps forward — but looks unlikely to make the original April deadline

A growing problem: Lead testing uncovers ‘deeply concerning issue’ in spirulina supply chain

Global demand for spirulina is booming, with the market for this superfood projected to reach $1.3 billion by 2032. But new testing revealed some cracks in quality and safety that suggest some top-selling products may expose consumers to elevated lead...

SANS 2026: State-level rules and class action trends raise new stakes for supplement brands

Dietary supplement companies may be focused on FDA activity in Washington, but at the Sports & Active Nutrition Summit (SANS), Rend Al‑Mondhiry, partner at Amin Wasserman Gurnani LLP, warned that some of the major risks are emerging much closer to home.